Sulconazole (Exelderm - ICI) is the latest imidazole antifungal marketed for topical use. Like other imidazoles it inhibits fungal cell membrane synthesis. The manufacturer claims that sulconazole acts rapidly and has a broad spectrum of activity against dermatophytes and yeasts, with a low relapse rate, and high patient acceptability and compliance. Does it excel, as the trade name implies?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.